Literature DB >> 29109607

Sofosbuvir with velpatasvir.

.   

Abstract

Entities:  

Year:  2017        PMID: 29109607      PMCID: PMC5662430          DOI: 10.18773/austprescr.2017.063

Source DB:  PubMed          Journal:  Aust Prescr        ISSN: 0312-8008


× No keyword cloud information.
  8 in total

Review 1.  Ledipasvir with sofosbuvir.

Authors: 
Journal:  Aust Prescr       Date:  2015-10-14

Review 2.  Daclatasvir.

Authors: 
Journal:  Aust Prescr       Date:  2015-10-01

3.  Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for chronic hepatitis C.

Authors: 
Journal:  Aust Prescr       Date:  2016-05-20

4.  Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.

Authors:  David Wyles; Norbert Bräu; Shyam Kottilil; Eric S Daar; Peter Ruane; Kimberly Workowski; Anne Luetkemeyer; Oluwatoyin Adeyemi; Arthur Y Kim; Brian Doehle; K C Huang; Erik Mogalian; Anu Osinusi; John McNally; Diana M Brainard; John G McHutchison; Susanna Naggie; Mark Sulkowski
Journal:  Clin Infect Dis       Date:  2017-07-01       Impact factor: 9.079

Review 5.  Elbasvir/grazoprevir.

Authors: 
Journal:  Aust Prescr       Date:  2017-02-01

6.  Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

Authors:  Graham R Foster; Nezam Afdhal; Stuart K Roberts; Norbert Bräu; Edward J Gane; Stephen Pianko; Eric Lawitz; Alex Thompson; Mitchell L Shiffman; Curtis Cooper; William J Towner; Brian Conway; Peter Ruane; Marc Bourlière; Tarik Asselah; Thomas Berg; Stefan Zeuzem; William Rosenberg; Kosh Agarwal; Catherine A M Stedman; Hongmei Mo; Hadas Dvory-Sobol; Lingling Han; Jing Wang; John McNally; Anu Osinusi; Diana M Brainard; John G McHutchison; Francesco Mazzotta; Tram T Tran; Stuart C Gordon; Keyur Patel; Nancy Reau; Alessandra Mangia; Mark Sulkowski
Journal:  N Engl J Med       Date:  2015-11-17       Impact factor: 91.245

7.  Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.

Authors:  Jordan J Feld; Ira M Jacobson; Christophe Hézode; Tarik Asselah; Peter J Ruane; Norbert Gruener; Armand Abergel; Alessandra Mangia; Ching-Lung Lai; Henry L Y Chan; Francesco Mazzotta; Christophe Moreno; Eric Yoshida; Stephen D Shafran; William J Towner; Tram T Tran; John McNally; Anu Osinusi; Evguenia Svarovskaia; Yanni Zhu; Diana M Brainard; John G McHutchison; Kosh Agarwal; Stefan Zeuzem
Journal:  N Engl J Med       Date:  2015-11-16       Impact factor: 91.245

8.  Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.

Authors:  Michael P Curry; Jacqueline G O'Leary; Natalie Bzowej; Andrew J Muir; Kevin M Korenblat; Jonathan M Fenkel; K Rajender Reddy; Eric Lawitz; Steven L Flamm; Thomas Schiano; Lewis Teperman; Robert Fontana; Eugene Schiff; Michael Fried; Brian Doehle; Di An; John McNally; Anu Osinusi; Diana M Brainard; John G McHutchison; Robert S Brown; Michael Charlton
Journal:  N Engl J Med       Date:  2015-11-16       Impact factor: 91.245

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.